Table of Contents

company-logo

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is based in San Diego, California.

Calidi Biotherapeutics Dividend Announcement

• Calidi Biotherapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Calidi Biotherapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Calidi Biotherapeutics Dividend History

Calidi Biotherapeutics Dividend Yield

Calidi Biotherapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Calidi Biotherapeutics stock? Use our calculator to estimate your expected dividend yield:

Calidi Biotherapeutics Financial Ratios

P/E ratio-0.70
PEG ratio-0.01
P/B ratio-1.47
ROE192.64%
Payout ratio0.00%
Current ratio0.19
Quick ratio0.19
Cash Ratio0.16

Calidi Biotherapeutics Dividend FAQ

Does Calidi Biotherapeutics stock pay dividends?
Calidi Biotherapeutics does not currently pay dividends to its shareholders.
Has Calidi Biotherapeutics ever paid a dividend?
No, Calidi Biotherapeutics has no a history of paying dividends to its shareholders. Calidi Biotherapeutics is not known for its dividend payments.
Why doesn't Calidi Biotherapeutics pay dividends?
There are several potential reasons why Calidi Biotherapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Calidi Biotherapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Calidi Biotherapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Calidi Biotherapeutics a dividend aristocrat?
Calidi Biotherapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Calidi Biotherapeutics a dividend king?
Calidi Biotherapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Calidi Biotherapeutics a dividend stock?
No, Calidi Biotherapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Calidi Biotherapeutics stocks?
To buy Calidi Biotherapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Calidi Biotherapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.